# POSLUMA

NDC: 69932-002
Generic name: flotufolastat F-18
Labeler / Manufacturer: Blue Earth Diagnostics
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20230525

FDA application: NDA216023

## Active ingredients

- FLOTUFOLASTAT F-18: 158 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69932-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69932-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=907ac4a4-a088-4826-ab50-cfc31985c9d4